FN1 and colorectal carcinoma: The serum IgA levels of anti-Fn-AhpC in patients with late-stage CRC (stage III-IV, n = 203) were remarkably higher than those in healthy subjects (P = 0.007, P < 0.05) and in early-stage CRC patients (P = 0.026, P < 0.05).